Concepedia

Atsushi TAKAO

AT

6

Publications

138

Citations

6

H-Index

1994

Active since

Affiliations

Eli Lilly (Japan)(Current)

Atsushi TAKAO is an author at Eli Lilly (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1994–2004

6

Publications

6

Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat

Ken-ichi Nezasa, Atsushi TAKAO, Kazuhiro Kimura et al. · Xenobiotica · 2002 · 56 citations

, , +20

A randomised dose-comparison trial of granisetron in preventing emesis in children with leukaemia receiving emetogenic chemotherapy

Yoshihiro Komada, T Matsuyama, Atsushi TAKAO et al. · European Journal of Cancer · 1999 · 23 citations

, , +8

Absorption, Distribution, and Excretion of DJ-927, a Novel Orally Effective Taxane, in Mice, Dogs, and Monkeys

Chiho Ono, Atsushi TAKAO, Ryo Atsumi · Biological and Pharmaceutical Bulletin · 2004 · 22 citations · Full text

Disposition of gemcitabine in rat and dog after single and multiple dosings

Y Esumi, Kouichi MITSUGI, Atsushi TAKAO et al. · Xenobiotica · 1994 · 14 citations

Placental transfer, lacteal transfer and plasma protein binding of gemcitabine

Y Esumi, Kouichi MITSUGI, Hideaki SEKI et al. · Xenobiotica · 1994 · 12 citations

, , +15

Rows per page

1–5 of 6